Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil is the Academic Director of the Centre for Clinical Hematology at the Queen Elizabeth Hospital, Birmingham, UK, and Professor of Haemato-oncology, at the University of Birmingham, Birmingham, UK.
Professor Craddock trained in hematology at the Hammersmith Hospital, London, the Institute of Molecular Medicine at the University of Oxford and the University of Washington, Seattle, USA.
He was elected President of the British Society of Blood and Marrow Transplantation in 2017 and is Chair of the UK Stem Cell Strategic Oversight Committee. Prof. Craddock was Medical Director of Anthony Nolan from 2010–2014 and led the development of the £24 million Birmingham Institute of Translational Medicine, which opened in 2015. His main research interests include the development of novel drug and transplant therapies in myeloid leukemias and he leads the Bloodwise UK Trials Acceleration Programme.
Prof. Craddock communicates the latest research updates in his field through his Twitter account, @charliecraddock.